The Science is here and we have to perfect it............is my opinion
I am also aware that immunotherapy treatments do not fully eradicate cancerous tumours without leaving some residual damage or without having significant side effects.
This will be the crux of what they are working on atm and trying to mitigate against. My understanding now is that this is where dosage/toxicity comes into the big picture. Scientists envisage this issue of significant side effects as a major challenge to immunotherapy. I believe we are close to the final stages of accomplishing this and for all we know this challenge might even be one of the last hurdles to clear.
Onwards and upwards and let the science, as we know it, provide us what we think it can
GLTAH
- Forums
- ASX - By Stock
- IMU
- The CF33, Vaxinia and Oncarlytics Deal
IMU
imugene limited
Add to My Watchlist
18.2%
!
1.3¢

The CF33, Vaxinia and Oncarlytics Deal, page-14
-
- There are more pages in this discussion • 252 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $97.07M |
Open | High | Low | Value | Volume |
1.2¢ | 1.4¢ | 1.1¢ | $625.7K | 50.56M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 5795292 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 3258567 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 5735292 | 0.012 |
35 | 10497532 | 0.011 |
118 | 35980571 | 0.010 |
37 | 19431668 | 0.009 |
13 | 4220748 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 3078567 | 8 |
0.014 | 10063029 | 39 |
0.015 | 6593187 | 20 |
0.016 | 6224494 | 27 |
0.017 | 7006978 | 10 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online